Edward J. Lewis

Identification of <i>N</i>-(4-Piperidinyl)-4-(2,6-dichlorobenzoylamino)-1<i>H</i>-pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design

Paul G. Wyatt, Andrew Woodhead, Valério Berdini et al. · Journal of Medicinal Chemistry · 2008 · 341 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Biological characterization of AT7519, a small-molecule inhibitor of cyclin-dependent kinases, in human tumor cell lines

Matthew Squires, Ruth E. Feltell, Nicola G. Wallis et al. · Molecular Cancer Therapeutics · 2009 · 172 citations

Medicine, Medicinal Chemistry, Oncology +15

Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Discovery of a Non-Alanine Lead Series with Dual Activity Against cIAP1 and XIAP

Gianni Chessari, Ildiko M. Buck, James E. H. Day et al. · Journal of Medicinal Chemistry · 2015 · 86 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth

George A. Ward, Edward J. Lewis, Jong Sook Ahn et al. · Molecular Cancer Therapeutics · 2018 · 74 citations

Medicine, Oncology, Pharmacology +17

Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP)

Emiliano Tamanini, Ildiko M. Buck, Gianni Chessari et al. · Journal of Medicinal Chemistry · 2017 · 71 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17